Cardiac Arrhythmias: Inherited Molecular Mechanisms

Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2004, Pages 336-348

  Goldstein, Steve A N ^a,b   Keating, Mark T ^c,d,e   Sanguinetti, Michael C ^f  

^a Section of Developmental Biology and Biophysics   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32444432619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9428-3.50024-X     Document Type: Chapter

References (103)

1. Kannel W, Cupples A, D'Agostino R Sudden death risk in overt coronary heart diseases: The Framingham study. Am Heart J 1987, 113:799-804.
2. Willich S, Levy D, Rocco M, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 1987, 60:801-806.
3. Sanguinetti MC, Jurkiewicz NK Two components of cardiac delayed rectifier K + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990, 96:195-215.
4. Sanguinetti MC, Tristani-Firouzi M Delayed and inward rectifier potassium channels. Cardiac Electrophysiology: From Cell to Bedside 2000, 79-86. WB Saunders, Philadelphia. D.P. Zipes, J. Jalife (Eds.).
5. Schwartz P, Moss A, Vincent G, et al. Diagnostic criteria for the long QT syndrome. Circulation 1993, 88:782-784.
6. Lazzara R Twisting of the points. J Am Coll Cardiol 1997, 29:843-845.
7. Moss AJ ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995, 92:2929-2934.
8. Jervell A, Lange-Nielsen F Congenital deaf-mutism, functional heart disease with prolongation of the QT interval, and sudden death. Am Heart J 1957, 54:59-68.
9. Romano C, Gemme G, Pongiglione R Artimie cardiach rare dell'eta pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossitica. Clin Pediatr 1963, 45:656-683.
10. Ward O A new familial cardiac syndrome in children. J Ir Med Assoc 1964, 54:103-106.
11. Roden DM Mechanisms and management of proarrhythmia. Am J Cardiol 1998, 82(4A):49I-57I.
12. Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure: The role of abnormal repolarization. Circulation 1994, 90:2534-2539.
13. Roden DM, Lazzara R, Rosen M, et al. Multiple mechanisms in the long-QT syndrome-current knowledge, gaps, and future directions. Circulation 1996, 94:1996-2012.
14. Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997, 336:1562-1567.
15. Abildskov J The sympathetic imbalance hypothesis of QT interval prolongation. J Cardiovasc Electrophysiol 1991, 2:355-359.
16. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
17. Chen QY, Kirsch GE, Zhang DM, et al. Genetic basis and molecular mechanism for idiopathic-ventricular fibrillation. Nature 1998, 392:293-296.
18. Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
19. Priori SG, Napalitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholamine polymorphic ventricular tachycardia. Circulation 2000, 102:r49-r53.
20. Splawski I, Tristani-Firouzi M, Lehmann MH, et al. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997, 17:338-340.
21. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12:17-23.
22. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80:805-811.
23. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001, 105:511-519.
24. Schott J, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995, 57:1114-1122.
25. Duggal P, Vesely MR, Wattanasirichaigoon D, et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Circulation 1998, 97:142-146.
26. Neyroud N, Tesson F, Denjoy I, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997, 15:186-189.
27. Hoorntje T, Alders M, van Tintelen P, et al. Homozygous premature truncation of the HERG protein: The human HERG knockout. Circulation 1999, 100:1264-1267.
28. Gellens M, George A, Chen L, et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA 1992, 89:554-558.
29. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102:1178-1185.
30. Catterall WA Molecular properties of voltage-sensitive sodium channels. Annu Rev Biochem 1986, 55:953-985.
31. Bennett PB, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376:683-685.
32. Dumaine R, Wang Q, Keating MT, et al. Multiple mechanisms of Na + channel-linked long-QT syndrome. Circ Res 1996, 78:916-924.
33. Martini B Wang Q, Keating Mt, Ventricular fibrillation without apparent heart disease: Description of six cases. Am Heart J 1989, 118:1203-1209.
34. Brugada J, Brugada R, Brugada P Right bundle branch block, ST segment elevation in leads V1-V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1997, 96:1151.
35. Krishnan SC, Antzelevitch C Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991, 69:277-291.
36. Keating M, Atkinson D, Dunn C, et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991, 704-706.
37. Lee MP, Hu R-J, Johnson LA, et al. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 1997, 15:181-185.
38. Yang WP, Levesque PC, Little WA, et al. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci USA 1997, 94:4017-4021.
39. Charlier C, Singh NA, Ryan SG, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998, 18:53-55.
40. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998, 18:25-29.
41. Yang WP, Levesque PC, Little WA, et al. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J Biol Chem 1998, 273:19419-19423.
42. Coucke PJ, Van Hauwe P, Kelley PM, et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 familes. Hum Mol Genet 1999, 8:1321-1328.
43. Kubisch C, Schroeder BC, Friedrich T, et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999, 96:437-446.
44. Wollnik B, Schroeder BC, Kubisch C, et al. Pathophysiological mechanisms of dominant and recessive KVLQT1 K + channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 1997, 6:1943-1949.
45. Wang Z, Tristani-Firouzi M, Xu Q, et al. Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol 1999, 10:817-826.
46. Barhanin J, Lesage F, Guillemara E, et al. K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384:78-80.
47. Sanguinetti MC, Curran ME, Zou A, et al. Coassembly Of K(V)Lqt1 and Mink (Isk) proteins to form cardiac I-Ks potassium channel. Nature 1996, 384:80-83.
48. Takumi T, Ohkubo H, Nakanishi S Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science 1988, 242:1042-1045.
49. Goldstein SA, Miller C Site-specific mutations in a minimal voltage-dependent K + channel alter ion selectivity and open-channel block. Neuron 1991, 7:403-408.
50. Freeman LC, Kass RS Expression of a minimal K + channel protein in mammalian cells and immunolocalization in guinea pig heart. Circ Res 1993, 73:968-973.
51. Blumenthal EM, Kaczmarek LK The minK potassium channel exists in functional and nonfunctional forms when expressed in the plasma membrane of Xenopus oocytes. J Neurosci 1994, 14:3097-3105.
52. Wang KW, Goldstein SAN Subunit composition of minK potassium channels. Neuron 1995, 14:1303-1309.
53. Tai K-K, Wang K-W, Goldstein SAN MinK potassium channels are heteromultimeric complexes. J Biol Chem 1997, 272:1654-1658.
54. Abbott GW, Goldstein SAN Potassium channel subunits encoded by the KCNE gene family: Physiology and pathophysiology of the MinK-related peptides (MiRPs). Mol Intervent 2001, 1:95-107.
55. Wang W, Xia J, Kass RS MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel. J Biol Chem 1998, 273:34069-34074.
56. Sesti F, Goldstein SAN Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. J Gen Physiol 1998, 112:651-664.
57. Yang Y, Sigworth F Single-channel properties of IKs potassium channels. J Gen Physiol 1998, 112:665-678.
58. Busch AE, Busch GL, Ford E, et al. The role of the IsK protein in the specific pharmacological properties of the IKs channel complex. Br J Pharmacol 1997, 122:187-189.
59. Sesti F, Tai KK, Goldstein SAN MinK endows the IKs potassium channel with sensitivity to internal TEA. Biophys J 2000, 79:1369-1378.
60. Marcus DC, Shen Z Slowly activating voltage-dependent K + conductance is apical pathway for K + secretion in vestibular dark cells. Am J Physiol 1994, 267(3):C857-C864. Pt 1.
61. Vetter DE, Mann JR, Wangemann P, et al. Inner ear defects induced by null mutation of the isk gene. Neuron 1996, 17:1251-1264.
62. Warmke J, Ganetzky B A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 1994, 91:3438-3442.
63. Morais Cabral JH, Lee A, Cohen SL, et al. Crystal structure and functional analysis of the HERG potassium channel N terminus: A eukaryotic PAS domain. Cell 1998, 95:649-655.
64. Sanguinetti MC, Jiang C, Curran ME, et al. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
65. Trudeau MC, Warmke JW, Ganetzky B, et al. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995, 269:92-95.
66. Smith PL, Baukrowitz T, Yellen G The inward rectification mechanism of the HERG cardiac potassium channel. Nature 1996, 379:833-836.
67. Spector PS, Curran ME, Zou A, et al. Fast inactivation causes rectification of the IKr channel. J Gen Physiol 1996, 107:611-619.
68. Zhou Z, Gong Q, Ye B, et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 1998, 74:230-241.
69. Chen J, Zou A, Splawski I, et al. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem 1999, 274:10113-10118.
70. Zhang M, Jiang M, Tseng G MiRP1 associates with Kv4.2 and modulates its gating function: A potential role as b subunit of cardiac transient outward channel?. Circ Res 2001, 88:1012-1019.
71. Yu H, Wu J, Potapova I, et al. MinK-related peptide 1: A beta sub-unit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res 2001, 88:E84-E87.
72. Sesti F, Abbott GW, Wei J, et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci 2000, 97:10613-10618.
73. Roden DM Taking the "idio" out of "idiosyncratic": Predicting torsades de pointes. Pacing Clin Electrophysiol 1998, 21:1029-1034.
74. Minardo JD, Heger JJ, Miles WM, et al. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. N Engl J Med 1988, 319:257-262.
75. Donger C, Denjoy I, Berthet M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997, 96:2778-2781.
76. Tawil R, Ptacek LJ, Pavlakis SG, et al. Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features. Ann Neurol 1994, 35:326-330. [See comments].
77. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001, 10(3):189-194.
78. Witchel HJ, Hancox JC Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current [Review]. Clin Exp Pharmacol Physiol 2000, 27:753-766.
79. Mitcheson JS, Chen J, Lin M, et al. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000, 97:12329-12333.
80. Mitcheson JS, Chen J, Sanguinetti MC Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J Gen Physiol 2000, 115:229-239.
81. del Camino D, Holmgren M, Liu Y, et al. Blocker protection in the pore of a voltage-gated K + channel and its structural implications. Nature 2000, 403:321-325.
82. Ficker E Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 1998, 82:386-395.
83. Lee KL, Jim MH, Tang SC, et al. QT prolongation and torsades de pointes associated with clarithromycin. Am J Med 1998, 104:395-396.
84. Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol 2001, 11:691-696.
85. Drici MD, Knollmann BC, Wang WX, et al. Cardiac actions of erythromycin: Influence of female sex. JAMA 1998, 280:1774-1776.
86. Nerbonne JM Molecular basis of functional voltage-gated K + channel diversity in the mammalian myocardium. J Physiol 2000, 525:285-298.
87. Keating MT, Sanguinetti MC Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001, 104:569-580.
88. Numaguchi H, Johnson JP, Peterson CI, et al. A sensitive mechanism for cation modulation of potassium current. Nat Neurosci 2000, 3:429-430.
89. Compton SJ, Lux RL, Ramsey MR, et al. Genetically defined therapy of inherited long-QT syndrome: Correction of abnormal repolarization by potassium. Circulation 1996, 94:1018-1022.
90. Moss AJ Update on MADIT: The Multicenter Automatic Defibrillator Implantation Trial. The long QT interval syndrome. Am J Cardiol 1997, 79:16-19.
91. Mohler PJ, Schott J-J, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrythmia and sudden cardiac death. Nature 2003, 421:634-639.
92. Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 2003, 107:2850-2856.
93. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003, 299:251-254.
94. Cheng CF, Kuo HC, Chien KR Genetic modifiers of cardiac arrhythmias. Trends Mol Med 2003, 9:59-66.
95. Gutstein DE, Morley GE, Tamaddon H, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001, 88:333-339.
96. Kuo HC, Cheng CF, Clark RB, et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001, 107:801-813.
97. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421:634-639.
98. Nguyen-Tran VT, Kubalak SW, Minamisawa S, et al. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell 2000, 102:671-682.
99. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003, 348:1866-1874.
100. Rottbauer W, Baker K, Wo ZG, et al. Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell 2001, 1:265-275.
101. Splawski I, Timothy KW, Tateyama M, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002, 297:1333-1336.
102. Tanaka M, Berul CI, Ishii M, et al. A mouse model of congenital heart disease: Cardiac arrhythmias and atrial septal defect caused by haploin-sufficiency of the cardiac transcription factor Csx/Nkx2.5. Cold Spring Harb Symp Quant Biol 2002, 67:317-325.
103. Wehrens XH, Lehnart SE, Huang F, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113:829-840.